FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 301 through 320 of 320

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
TWST Nasdaq Twist Bioscience Corporation 2836
TXG Nasdaq 10x Genomics, Inc. 2836
UNCY Nasdaq Unicycive Therapeutics, Inc. 2836
VCYT Nasdaq Veracyte, Inc. 2836
VICP Over the counter Vicapsys Life Sciences, Inc. 2836
VIVS Nasdaq VivoSim Labs, Inc. 2836
VKTX Nasdaq Viking Therapeutics, Inc. 2836
VNDA Nasdaq Vanda Pharmaceuticals Inc. 2836
VRTX Nasdaq Vertex Pharmaceuticals Incorporated 2836
VSTM Nasdaq Verastem, Inc. 2836
VTGN Nasdaq Vistagen Therapeutics, Inc. 2836
VTVT Nasdaq vTv Therapeutics Inc. 2836
VYGR Nasdaq Voyager Therapeutics, Inc. 2836
WHWK Nasdaq Whitehawk Therapeutics, Inc. 2836
XENE Nasdaq Xenon Pharmaceuticals Inc. 2836
XFOR Nasdaq X4 Pharmaceuticals, Inc. 2836
XGN Nasdaq Exagen Inc. 2836
XLO Nasdaq Xilio Therapeutics, Inc. 2836
ZBIO Nasdaq Zenas BioPharma, Inc. 2836
ZNTL Nasdaq Zentalis Pharmaceuticals, Inc. 2836
Results 300 through 320 of 320